FDA approves extended depth-of-focus IOL
On July 15, the Food and Drug Administration (FDA) approved Tecnis Symfony intraocular lens (IOL), the first IOL that provides cataract patients with an extended depth-of-focus, which helps…
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.